LALAIF Expands Global Presence with Strategic Exports to Taiwan, China, and Japan

LALAIF, a premium bio-cosmetic brand based on advanced skin penetration technology, is accelerating its global expansion with major distribution agreements and export achievements in Taiwan, China, and Japan.
 

[Image by LALAIF]

Most recently, LALAIF signed an exclusive distribution agreement with Woh Medical, one of Taiwan’s largest distributors of medical devices and cosmetic products. The initial shipment included 3,000 units each of the brand’s Booster Serum and Cream Serum, totaling 6,000 units, with an estimated contract value of KRW 500 million. The partnership is expected to expand further with regular reorders and product line extensions.
 
Woh Medical is a trusted distributor of globally recognized brands such as Motiva (medical implants), JuveLook (premium fillers), making this partnership a strong foundation for LALAIF’s entry into the broader Asian and global markets. The deal was facilitated through a strategic partnership with UMECO Group, a global export/import company with over 40 years of international business experience.
 
In China, LALAIF officially launched on Douyin Commerce (TikTok China), achieving impressive results with revenue exceeding KRW 100 million in the first month. Meanwhile, in Japan, the brand is gaining traction through a collaboration with PR agency k-pods, generating buzz on social media and positioning LALAIF as a rising K-beauty brand.
 

[Image by LALAIF]

LALAIF is currently in distribution negotiations with partners in 23 countries, including Israel, India, Indonesia, the Philippines, Jordan, and Hong Kong. Clinical trials are also underway in collaboration with local medical professionals and institutions to ensure safety and efficacy in each target market.
 
In addition, acclaimed Korean actor Ryu Seung-ryong has joined LALAIF as a strategic investor and brand ambassador, expressing strong belief in the brand’s technology and philosophy.
 
A LALAIF spokesperson stated, “With a foundation in science-backed technology and clinical performance, we are confident in our ability to connect with global consumers. We will continue to strengthen our international competitiveness by partnering with trusted global distributors.”
  

정현식 기자